Literature DB >> 1245267

Norepinephrine, epinephrine, and dopamine contents of the cardiovascular system in long-term diabetics.

B Neubauer, N J Christensen.   

Abstract

Norepinephrine, epinephrine, and dopamine concentrations were studied in the cardiovscular system of postmortem material obtained from six long-term diabetics and six control subjects. Norepinephrine concentration was considerably reduced in the cardiovascular system of the diabetic patients. The mean norepinephrine concentration in the apex of the heart, the radial artery, the posterior tibial artery, and the femoral artery in the diabetics averaged 6, 9, 12, and 20 per cent, respectively, of the corresponding mean values in the controls. Epinephrine was present in the cardiovascular system in the controls but in small amounts in comparision with norepinephrine. There was no correlation between the epinephrine and the norepinephrine concentrations in the tissue. In the diabetics the epinephrine concentration in the heart and in the arteries did not differ from the values obtained in the controls. The dopamine concentration averaged 11 per cent of the norepinephrine concentration in the cardiovascular system in the controls. There was a strong correlation between tissue concentrations of dopamine and of norepinephrine. In the diabetics the dopamine concentration was reduced, but relatively less than that of norepinephrine, and constituted 53 per cent of the norepinephrine concentration. It is suggested that the depletion of the norepinephrine stores in the heart in diabetic patients may in part be responsible for their reduced survival rate in acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1245267     DOI: 10.2337/diab.25.1.6

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  17 in total

1.  Reduced noradrenaline turnover in streptozotocin-induced diabetic rats.

Authors:  T Yoshida; H Nishioka; Y Nakamura; M Kondo
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

2.  Baroreflex control of plasma norepinephrine and heart period in healthy subjects and diabetic patients.

Authors:  D L Eckberg; S W Harkins; J M Fritsch; G E Musgrave; D F Gardner
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 3.  Catecholamines and diabetes mellitus.

Authors:  N J Christensen
Journal:  Diabetologia       Date:  1979-04       Impact factor: 10.122

4.  Dependence of the cardiovascular effects of pindolol on the individual sympathetic nervous activity.

Authors:  N Tanaka; K Kawahira; A Kudo; T Kashima; H Tanaka
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Diabetic cardiopathy.

Authors:  T Ledet; B Neubauer; N J Christensen; K Lundbaek
Journal:  Diabetologia       Date:  1979-04       Impact factor: 10.122

Review 6.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

7.  Is abnormal iodine-123-MIBG kinetics associated with left ventricular dysfunction in patients with diabetes mellitus?

Authors:  T Sugiyama; C Kurata; K Tawarahara; T Nakano
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

8.  The role of gender differences in beta-adrenergic receptor responsiveness of diabetic rat heart.

Authors:  Ayca Bilginoglu; Figen Amber Cicek; Mehmet Ugur; Hakan Gurdal; Belma Turan
Journal:  Mol Cell Biochem       Date:  2007-06-19       Impact factor: 3.396

9.  Altered cardiac adrenergic neurotransmission in streptozotocin-induced diabetic rats.

Authors:  S Gando; Y Hattori; M Kanno
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

10.  Asymptomatic peripheral nerve dysfunction and vascular reactivity in IDDM patients with and without microalbuminuria.

Authors:  C W Bodmer; E A Masson; M W Savage; S Benbow; A W Patrick; G Williams
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.